Skip to content
Open access · CC-BY via OpenAlex

Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes

Ana Raimundo, Sofia Ferreira, Francisco Abraham Tomás-Barberán, Cláudia Nunes dos Santos, Regina Menezes

Nutrients · 2021 · ▲ 40 citations

Abstract

Diabetes remains one of the leading causes of deaths and co-morbidities in the world, with tremendous human, social and economic costs. Therefore, despite therapeutics and technological advancements, improved strategies to tackle diabetes management are still needed. One of the suggested strategies is the consumption of (poly)phenols. Positive outcomes of dietary (poly)phenols have been pointed out towards different features in diabetes. This is the case of ellagitannins, which are present in numerous foodstuffs such as pomegranate, berries, and nuts. Ellagitannins have been reported to have a multitude of effects on metabolic diseases. However, these compounds have high molecular weight and do not reach circulation at effective concentrations, being metabolized in smaller compounds. After being metabolized into ellagic acid in the small intestine, the colonic microbiota hydrolyzes and metabolizes ellagic acid into dibenzopyran-6-one derivatives, known as urolithins. These low molecular weight compounds reach circulation in considerable concentrations ranging until micromolar levels, capable of reaching target tissues. Different urolithins are formed throughout the metabolization process, but urolithin A, isourolithin A, and urolithin B, and their phase-II metabolites are the most frequent ones. In recent years, urolithins have been the focus of attention in regard to their effects on a multiplicity of chronic diseases, including cancer and diabetes. In this review, we will discuss the latest advances about the protective effects of urolithins on diabetes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/nu13124285
Canonical
link ↗
Fetched
2026-11-09 MST

Cite this

APA
Raimundo, A., Ferreira, S., Tomás-Barberán, F.A., Santos, C.N.D., &amp; Menezes, R. (2021). Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes. <em>Nutrients</em>. https://doi.org/10.3390/nu13124285
Vancouver
Raimundo A, Ferreira S, Tomás-Barberán FA, Santos CND, Menezes R. Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes. Nutrients. 2021. doi:10.3390/nu13124285.
BibTeX
@article{ana2021Urolit, title = {Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes}, author = {Ana Raimundo and Sofia Ferreira and Francisco Abraham Tomás-Barberán and Cláudia Nunes dos Santos and Regina Menezes}, journal = {Nutrients}, year = {2021}, doi = {10.3390/nu13124285}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings